July 2010 Issue of MMM
Welcome to the big, fat July issue, featuring our extensive annual coverage of healthcare agencies.
Independent shop stays afloat with 4-5% growth, 16 new brands under its belt
After merge with sibling Lab9, losing largest account, shop ends year up
Three-year-old shop strikes gold with global and high-science launches
Shop's three-pronged approach was expanded to five, resulting in some gains
Shop finds opportunities in tough times, building on its AOR business
New business model, expanded digital offerings sets up firm for the future
Bringing digital firm in-house sets smallish shop on the path to growth
Decade-old shop dug out of 2009's hole and started this year off right
Digital shop evolves into 'experience agency' with multichannel projects
After an unsettling year, four distinct firms were bonded back together
Six-year-old shop grows in the double digits, hopes to break $20 million mark
Powerhouse firm expands globally and locally with staff, new assignments
Narrowed healthcare focus helped mostly interactive firm land 20 wins
WPP shop had 'best year ever' post-consolidation, revamped traditional offerings
International growth, explosive ROI propelled shop into strong first quarter
The year brings a mixed bag of wins, losses and a big launch
Consolidation under one umbrella leads to shared resources with 37% growth
Digital shop's growth continues to explode with 11 new accounts
An award-winning year was capped off by double-digit growth and 10 new accounts
Product launches, new biz for smaller firms help shop retain bold reputation
Agency rallies under new president and strategic team, achieves record year
Firm finished first year having doubled in size, on track for continued growth
Organic wins, diversifying efforts pay off with overall growth for conflict shop
With almost three decades in the biz, shop continues building and growing
Euro's largest firm stays on course for 'robust' growth with strong organic wins
Independent digital shop experiences explosive growth in award-winning year
Tough economic year spawned positive changes for growing firm
Firm had double-digit growth and landed AOR assignments in 'energizing year'
Acquisition of digital shop helps boost firm's revenue into the double digits
Expanded offerings and a foray into mobile health boost firm's growth
Firm continues to get bigger, adding new business while growing organically
'Crisis year' nets powerhouse agency new accounts, larger global footprint
A year of highs and lows was capped off by significant wins from Genentech
Huge first-quarter gains, new business help Texas shop shine in bleak year
Euro firm spins off as Havas conflict shop, sets sights on global market
Educational shop launching online programs, lands work from Big Pharma
Firm looks to increase its service offerings, break away from digital title
Overall company growth and non-pitch wins fuel double-digit upswing in revenue
Digital shop restructures at executive level, expands from coast to coast
Shop trying to stay 'healthy' with disease awareness programs, managed care
Organic growth, thriving med ed division help firm overcome its rebuilding year
Firm sees explosive growth with 61% boost in revenue, 62 new hires
'Next-generation digital agency' added five new accounts to its roster in 2009
'Idea partner' had an award-winning year, continues challenging status quo
Slow and steady growth helped San Francisco firm stay above the red line
An impressive number of wins came in for firm during an otherwise 'flat' year
Customer survey gave firm new insight into clients' needs, fuels new direction
After a flat '09, DTC shop blends CRM, media offerings with consumer sibs
Agency places big bet on social media but sees some budgets cut
Relatively new shop finds its footing with AOR work, product launches
Shop broadens roster with non-pharma accounts, predicting winning year
Creative overhaul nets agency 15 new brands, pushing revenue to $15 million
After a 'holding year,' revenue is trending up, new business rolling in
Firm working to live up to its 'dynamic and explosive' name by looking globally
Agency snares second big consolidation in two years, retools for healthcare's future
Midsize shop sees big-time J&J win, but growth still challenging
Frugal firm saw revenue hit an upswing after careful preparation in 2009
Interactive agency partnership proves fruitful in an otherwise bumpy year
Firm stayed afloat by retaining clients, utilizing healthcare reform expertise
Brand recognition leads to an award-winning year for nearly 25-year-old firm
New standalone amps up professional marketing and digital offerings
Retooled agency lands 15 brands, hopes to build off '09 investments
Four-year-old agency finds luck with new name, divisions and project work
Powerhouse agency acquires Wishbone, grows organically with Big Pharma clients
Nearing its 30th anniversary, shop looks to the future in terms of handling growth
Record gains, 26 new assignments help firm overcome difficult economic year
Saatchi's PA outpost sees a solid year, despite mergers at two key clients
Consumer firm stays 'positive' with big brands, more proactive health work
Firm puts collaboration with clients, digital skills at the forefront of operations
Cardio karma helps agency bag two CV wins, retain Vytorin/Zetia accounts
'Flexible' shop provides strategy to its clients, grows at a steady pace
Fast-acting agency pounces on work from GSK, Novartis and Jazz
New business model wins over clients, brings in AOR and project work for firm
Small wins and increased digital work holds Chicago agency together
Shop meets goal of enhancing digital offerings by being acquired by Rosetta
As much as I love new vaccine technology, I also hate getting too excited about studies that take place in mice, especially when you consider ...
Amgen has deployed "500 to 1,000" reps in support of Prolia, a biologic osteoporosis treatment that received FDA approval June 1.
Novartis was fined $250 million in a class action suit revealing discriminatory gender policies reminiscent of the 1950s.
Featuring news about GlaxSmithKline, Otsuka Pharma, Bristol-Myers Squibb, Pfizer and Merck
It's no secret that obesity and its nasty spawn, type 2 diabetes, have reached epic proportions.
Merck Serono announced the launch of a global MS awareness campaign calling for "script concepts" on the topic of multiple sclerosis.
Millennials are less trusting of traditional medical sources including doctors, nurses, advocacy groups, pharmacists and even Google searches, according to a study.
'Tis the season for a blizzard of meetings, white boards, sticky notes and PowerPoint. It's August, and for most pharma companies and their agency partners, ...
It's time pharma and health care company leaders heard an unequivocal message: Social media is the most important evolution in customer engagement since DTC went ...
The biggest piece of social legislation since Medicare has passed. The sweeping healthcare reform bill will touch the lives of all Americans, and even more ...
What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.
A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.